Mannoside Glycolipid Conjugates Display Antiviral Activity Against Ebola Virus-Reference-Cited by-同舟云学术

Mannoside Glycolipid Conjugates Display Antiviral Activity Against Ebola Virus

Published:2018-09-17 Issue:suppl_5 Volume:218 Page:S666-S671
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Reynard Olivier¹,Schaeffer Evelyne²,Volchkova Valentina A¹,Cimarelli Andrea³,Mueller Christopher G²,Volchkov Viktor E¹

Affiliation:

1. Laboratory Molecular Basis of Viral Pathogenicity, Centre International de Recherche en Infectiologie, INSERM, University of Lyon, Université Claude Bernard Lyon, ENS de Lyon, CNRS, UMR, Lyon, France

2. CNRS, Université de Strasbourg, UPR, Department of Immunology, Immunopathology and Therapeutic Chemistry, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France

3. Laboratory Host Pathogen Interaction During Lentiviral Infection, Centre International de Recherche en Infectiologie, INSERM, University of Lyon, Université Claude Bernard Lyon, ENS de Lyon, CNRS, UMR, Lyon, France

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/218/suppl_5/S666/26689901/jiy464.pdf

Reference27 articles.

1. Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus;Messaoudi;Nat Rev Microbiol,2015

2. Pathophysiology of Ebola virus infection: current challenges and future hopes;Rivera;ACS Infect Dis,2015

3. Ebola virus: a clear and present danger;Burd;J Clin Microbiol,2015

4. Clinical and virological characteristics of Ebola virus disease patients treated with favipiravir (T-705)-Sierra Leone, 2014;Bai;Clin Infect Dis,2016

5. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus;Bixler;Antiviral Res,2018